Valuing an optometry practice requires systematic analysis of patient economics, service mix, clinical capability, and operational efficiency aligned with consolidator expectations. Your foundation starts with understanding EBITDA—earnings before interest, taxes, depreciation, and amortization—which isolates operational profitability independent of ownership structure. For optometry practices, EBITDA typically ranges 4x-6x at exit, with premier practices reaching 6.5x-7x multiples. Most optometry practices trade at 2.0x-2.8x SDE (seller's discretionary earnings), reflecting strong cash generation and recurring patient revenue patterns.

The buyer universe spans national consolidators (VSP, EssilorLuxottica), PE-backed platforms, retail optometry chains, and health system acquisitions. Each prioritizes different metrics but all focus heavily on optical capture rates, medical optometry mix, associate retention, contact lens revenue, and patient recall effectiveness. National consolidators emphasize roll-up potential and brand leverage. Regional operators focus on market consolidation. PE-backed platforms seek practices with clinical diversification and recurring revenue models. Understanding your ideal buyer profile helps you optimize metrics that matter most to them and position your practice for premium valuation.

Optical capture rate is the primary operational metric determining optometry practice valuation. Practices achieving 65%+ optical capture rates receive 5.5x-6.5x EBITDA multiples, while practices below 50% capture often trade at 4x-4.5x multiples. This 35-45% valuation spread reflects consolidator confidence in patient monetization and in-office eyewear economics. Optical capture represents the percentage of patients who purchase eyewear through your practice rather than referral to external labs. High capture rates indicate strong patient relationships, competitive frame selection, attractive pricing, and effective dispensing processes. Consolidators specifically target high-capture practices because they can model predictable eyewear revenue per exam. Database analytics tracking capture trends by patient demographic and refraction type strengthen buyer confidence. If your practice operates below 55% capture, frame selection expansion and pricing optimization become the highest-ROI pre-sale investments.

Medical optometry service mix significantly expands patient lifetime value and valuation multiples. Practices generating 25%+ revenue from medical optometry services (dry eye therapy, glaucoma monitoring, disease management) receive 1.3x-1.5x EBITDA premiums, representing 30-50% valuation uplift. Medical optometry creates recurring patient relationships that justify 3-4 annual visits compared to 1-2 for routine vision correction alone. Services like dry eye therapy generate recurring prescription revenue and patient touchpoints. Glaucoma and diabetic eye disease management align with insurance reimbursement models that support higher service fees. Consolidators value medical optometry highly because insurance payers recognize medical codes, justifying premium reimbursement. Documented medical optometry revenue attribution and clinical outcome metrics add significant buyer confidence. If your practice operates as vision correction only, medical optometry service launch can increase valuation by $300K-$700K over 18-24 months.

Associate optometrist structure directly impacts valuation multiples and buyer appeal. Solo-optometrist practices trade at material discounts compared to practices with associates because founder-dependency creates significant buyer risk. A single associate optometrist adds 40-50% to practice valuation and demonstrates operational scalability. Multiple associates unlock even greater valuation multiples while simultaneously enabling the founding optometrist to transition away from clinical delivery. Consolidators specifically target multi-optometrist practices for roll-up strategies and geographic expansion. Associates also provide schedule flexibility, extended hours, and vacation coverage that improve patient access metrics consolidators can leverage post-acquisition. Documented associate retention agreements and professional development investment significantly strengthen buyer confidence. Revenue per optometrist benchmarking against regional norms helps establish fair associate compensation and practice productivity standards.

Contact lens revenue diversification creates sticky patient relationships and high-margin revenue streams. Optometry practices generating 20%+ of total revenue from contact lens sales demonstrate strong patient engagement and advanced clinical expertise. Contact lens patients typically generate 2-3 additional annual visits for lens fits, adjustments, and refills, creating predictable recurring revenue. Contact lens services operate at 60-70% gross margins, substantially exceeding eyeglass margins and supporting practice profitability. Specialized contact lens services (orthokeratology, scleral lenses, presbyopic solutions) enable premium positioning and attract patient referrals. Consolidators value contact lens revenue highly because it creates multiple patient touchpoints and improves lifetime value significantly. Documented contact lens revenue growth and patient retention metrics add buyer confidence. If your practice operates below 15% contact lens revenue, lens fitting development can increase valuation by $150K-$400K through improved patient lifetime value.

Diagnostic technology infrastructure—OCT imaging, fundus cameras, and modern EHR systems—demonstrates clinical sophistication and patient care quality. Optometry practices equipped with optical coherence tomography (OCT) and fundus camera imaging demonstrate premium positioning and enable earlier disease detection. Modern diagnostic technology strengthens medical optometry development, supports clinical decision-making, and improves patient relationships through enhanced detection and monitoring. Technology-enabled practices typically command 10-15% valuation premiums compared to basic-operation practices. Modern EHR systems with integrated patient communication, automated appointment reminders, and recall management add operational efficiency that consolidators value and can leverage post-acquisition. Technology investment signals commitment to clinical excellence and operational modernization. Documented technology adoption rates and clinical outcome metrics strengthen buyer confidence.

For deeper analysis of related healthcare verticals, explore medical practice valuation models, audiology business acquisition trends, and dental practice acquisition multiples to understand how adjacent healthcare businesses address comparable buyer evaluation frameworks.

Timing your sale around strong financial periods and operational milestones matters significantly. Practices with 3+ years of documented revenue growth, improving margins, expanding medical optometry mix, and demonstrated associate retention create more confident buyer projections. Conversely, selling during transitional periods (associate turnover, technology implementation, service launch disruption) often reduces offers by 20-30%. A professional business valuation typically costs $6K-$12K and provides critical documentation for buyer confidence and financing conversations. Related industries that follow similar consolidation dynamics include Audiology / Hearing Aid Center.